Drugs Approved for Stomach (Gastric) Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for stomach (gastric) cancer. The list includes generic and brand names. This page also lists common drug combinations used in stomach (gastric) cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.

The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in stomach (gastric) cancer that are not listed here.

Drugs Approved for Stomach (Gastric) Cancer

Capecitabine
Cyramza (Ramucirumab)
Docetaxel
Doxorubicin Hydrochloride
Enhertu (Fam-Trastuzumab Deruxtecan-nxki)
5-FU (Fluorouracil Injection)
Fam-Trastuzumab Deruxtecan-nxki
Fluorouracil Injection
Herceptin (Trastuzumab)
Keytruda (Pembrolizumab)
Lonsurf (Trifluridine and Tipiracil Hydrochloride)
Mitomycin
Nivolumab
Nivolumab and Hyaluronidase-nvhy
Opdivo (Nivolumab)
Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
Pembrolizumab
Ramucirumab
Taxotere (Docetaxel)
Tevimbra (Tislelizumab-jsgr)
Tislelizumab-jsgr
Trastuzumab
Trifluridine and Tipiracil Hydrochloride
Vyloy (Zolbetuximab-clzb)
Xeloda (Capecitabine)
Zolbetuximab-clzb

Drug Combinations Used in Stomach (Gastric) Cancer

FU-LV
TPF
XELIRI

Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors

Afinitor (Everolimus)
Afinitor Disperz (Everolimus)
Everolimus
Lanreotide Acetate
Somatuline Depot (Lanreotide Acetate)